ASKLEPIOS BIOPHARMACEUTICAL INC
Summary
Asklepios Biopharmaceutical operates as a AAV gene therapy company. The Company offers end-to-end gene therapy platform includes scaled-up manufacturing with its Pro10 cell line, AAV capsid library, and clinical programs for a range of genetic disease indications. Asklepios Biopharmaceutical serves customers in the State of North Carolina.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Richard Jude Samulski
Chief Scientific Officer and Co-Founder
Sheila Ann Mikhail
CEO
Tim Trost
CFO
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers